🇺🇸 FDA

Company profile · Sponsor

Seaport

Seaport Therapeutics

SPTX · NYSE pharma BOSTON, MA, USA
Pipeline
3
Drugs
0
Patents
1

Quick answer

Seaport (SPTX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker SPTX
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0002042347

Pipeline (3)

Search pipeline →

  1. A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious Distress

    Seaport

    Major Depressive Disorder (MDD), with or without Anxious Distress

    phase 2 other active

    1 trial

  2. Placebo for SPT-300

    Seaport

    Major Depressive Disorder (MDD), with or without Anxious Distress

    phase 2 small molecule active

    1 trial

  3. SPT-300

    Seaport

    Major Depressive Disorder (MDD)

    phase 2 small molecule active

    2 trials

Patents (1)

Search patents →

  1. US 12178875

    Lymphatic system-directing lipid prodrugs

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Seaport?

Seaport (SPTX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Seaport sponsor?

We track 3 ClinicalTrials.gov-linked programs for Seaport, including A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious Distress and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Seaport company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.